Literature DB >> 32506450

Late diagnosis of chronic granulomatous disease.

T Barkai1, R Somech1,2,3, A Broides4, R Gavrieli5, B Wolach3,5,6, N Marcus3,7, D Hagin3,8, T Stauber1,2,3.   

Abstract

Modern era advancements in medical care, with improved treatment of infections, can result in delayed diagnosis of congenital immunodeficiencies. In this study we present a retrospective cohort of 16 patients diagnosed with Chronic Granulomatous Disease (CGD) at adulthood. Some of the patients had a milder clinical phenotype, but others had a classic phenotype with severe infectious and inflammatory complications reflecting a profoundly impaired neutrophil function. It is therefore of great importance to investigate the individual journey of each patient through different misdiagnoses and the threads which led to the correct diagnosis. Currently the recommended definitive treatment for CGD is hematopoietic stem cell transplantation (HSCT). Although survival of our patients to adulthood might argue against the need for early HSCT during infancy, we claim that the opposite is correct, as most of them grew to be severely ill and diagnosed at a stage when HSCT is debatable with potentially an unfavorable outcome. This cohort stresses the need to increase awareness of this severe congenital immunodeficiency among clinicians of different specialties who might be treating undiagnosed adult patients with CGD.
© 2020 British Society for Immunology.

Entities:  

Keywords:  CGD; chronic granulomatous disease; misdiagnosis; primary immunodeficiency

Year:  2020        PMID: 32506450      PMCID: PMC7419865          DOI: 10.1111/cei.13474

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  43 in total

1.  Allogeneic Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: a Single-Center Prospective Trial.

Authors:  Mark Parta; Corin Kelly; Nana Kwatemaa; Narda Theobald; Diane Hilligoss; Jing Qin; Douglas B Kuhns; Christa Zerbe; Steven M Holland; Harry Malech; Elizabeth M Kang
Journal:  J Clin Immunol       Date:  2017-07-28       Impact factor: 8.317

Review 2.  Francisella philomiragia: Think of Chronic Granulomatous Disease.

Authors:  Angel Robles-Marhuenda; Marco Vaca; Pilar Romero; Antonio Ferreira; Eduardo López-Granados; Francisco Arnalich
Journal:  J Clin Immunol       Date:  2018-04-16       Impact factor: 8.317

3.  Chronic Granulomatous Disease in Patients Reaching Adulthood: A Nationwide Study in France.

Authors:  Bertrand Dunogué; Benoit Pilmis; Nizar Mahlaoui; Caroline Elie; Hélène Coignard-Biehler; Karima Amazzough; Nicolas Noël; Hélène Salvator; Emilie Catherinot; Louis-Jean Couderc; Harry Sokol; Fanny Lanternier; Fanny Fouyssac; Julie Bardet; Jacinta Bustamante; Marie-Anne Gougerot-Pocidalo; Vincent Barlogis; Agathe Masseau; Isabelle Durieu; Marc Lecuit; Felipe Suarez; Alain Fischer; Stéphane Blanche; Olivier Hermine; Olivier Lortholary
Journal:  Clin Infect Dis       Date:  2017-03-15       Impact factor: 9.079

4.  Two X-linked chronic granulomatous disease patients with unusual NADPH oxidase properties.

Authors:  Baruch Wolach; Arnon Broides; Tal Zeeli; Ronit Gavrieli; Martin de Boer; Karin van Leeuwen; Jacov Levy; Dirk Roos
Journal:  J Clin Immunol       Date:  2011-05-21       Impact factor: 8.317

5.  Residual NADPH oxidase and survival in chronic granulomatous disease.

Authors:  Douglas B Kuhns; W Gregory Alvord; Theo Heller; Jordan J Feld; Kristen M Pike; Beatriz E Marciano; Gulbu Uzel; Suk See DeRavin; Debra A Long Priel; Benjamin P Soule; Kol A Zarember; Harry L Malech; Steven M Holland; John I Gallin
Journal:  N Engl J Med       Date:  2010-12-30       Impact factor: 91.245

6.  Common severe infections in chronic granulomatous disease.

Authors:  Beatriz E Marciano; Christine Spalding; Alan Fitzgerald; Daphne Mann; Thomas Brown; Sharon Osgood; Lynne Yockey; Dirk N Darnell; Lisa Barnhart; Janine Daub; Lisa Boris; Amy P Rump; Victoria L Anderson; Carissa Haney; Douglas B Kuhns; Sergio D Rosenzweig; Corin Kelly; Adrian Zelazny; Tamika Mason; Suk See DeRavin; Elizabeth Kang; John I Gallin; Harry L Malech; Kenneth N Olivier; Gulbu Uzel; Alexandra F Freeman; Theo Heller; Christa S Zerbe; Steven M Holland
Journal:  Clin Infect Dis       Date:  2014-12-23       Impact factor: 9.079

Review 7.  Primary Immune Deficiencies in the Adult: A Previously Underrecognized Common Condition.

Authors:  Elli Rosenberg; Peter B Dent; Judah A Denburg
Journal:  J Allergy Clin Immunol Pract       Date:  2016 Nov - Dec

8.  Chronic granulomatous disease. Report on a national registry of 368 patients.

Authors:  J A Winkelstein; M C Marino; R B Johnston; J Boyle; J Curnutte; J I Gallin; H L Malech; S M Holland; H Ochs; P Quie; R H Buckley; C B Foster; S J Chanock; H Dickler
Journal:  Medicine (Baltimore)       Date:  2000-05       Impact factor: 1.889

9.  Biosynthetic human GM-CSF modulates the number and affinity of neutrophil f-Met-Leu-Phe receptors.

Authors:  R H Weisbart; D W Golde; J C Gasson
Journal:  J Immunol       Date:  1986-12-01       Impact factor: 5.422

Review 10.  Attending to warning signs of primary immunodeficiency diseases across the range of clinical practice.

Authors:  Beatriz Tavares Costa-Carvalho; Anete Sevciovic Grumach; José Luis Franco; Francisco Javier Espinosa-Rosales; Lily E Leiva; Alejandra King; Oscar Porras; Liliana Bezrodnik; Mathias Oleastro; Ricardo U Sorensen; Antonio Condino-Neto
Journal:  J Clin Immunol       Date:  2013-11-16       Impact factor: 8.317

View more
  3 in total

1.  Late diagnosis and advances in genetics of chronic granulomatous disease.

Authors:  G Di Matteo; A Finocchi
Journal:  Clin Exp Immunol       Date:  2020-12-13       Impact factor: 4.330

2.  Clinical & Experimental Immunology: Highlights of 2020.

Authors:  L S Taams; R S Taylor
Journal:  Clin Exp Immunol       Date:  2021-01       Impact factor: 4.330

3.  Effects of voriconazole on population pharmacokinetics and optimization of the initial dose of tacrolimus in children with chronic granulomatous disease undergoing hematopoietic stem cell transplantation.

Authors:  Xiao Chen; Dongdong Wang; Jianger Lan; Guangfei Wang; Lin Zhu; Xiaoyong Xu; Xiaowen Zhai; Hong Xu; Zhiping Li
Journal:  Ann Transl Med       Date:  2021-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.